Study of the Efficacy of PedyPhar® Ointment on the Diabetic Foot Ulcers
Status:
Terminated
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
Clinical Trial Phase III-b
Study Sponsor:
European Egyptian Pharmaceutical Industries
Sample Size:
120 patients (60 per arm)
Study Population:
Patients with Diabetic foot ulcer of any stage after proper surgical treatment - if needed.
Those patients will be recruited from patients attending the Diabetic foot Center at Faculty
of Medicine - Alexandria University and the outpatient clinic at Faculty of Medicine, Cairo
University.
Recruitment Period: 9 months
Dose application: thick layer of 2-3 mm applied to the dressing then dressing applied to the
ulcer.
Endpoints: Complete healing of the ulcer OR 5 months of application of the ointment whichever
comes first